rsvvw CONFERENCE 2017 - 4TH RESVINET MEETING
We are delighted to announce the RSV Vaccines For The World conference 2017 which is organized by ReSViNET. The goal of the conference is to bring together the scientific data and expertise (mainly focusing on vaccine developments) and connecting the stakeholders involved in RSV research e.g. scientists, physicians, pharmaceutical companies, regulators and representatives from governmental bodies. Researchers and physicians from all over the world are invited to join the discussions and share their knowledge. Specifically, scientists and physicians from low- and middle income countries (LMICs) and young researchers are being encouraged and supported to participate in this meeting. This year, the conference will be held on 29 November-01 December in Malaga, Spain
For more information about attending and/or sponsorhips possibilities please contact
Mrs. Leyla Kragten-Tabatabaie via email@example.com.
LOCATION AND ACCOMMODATION
RSV Vaccines for the World 2017 will be held in the heart of the Spanish city Málaga, in Cine Albéniz. Cine Albéniz is an old characteristic cinema which is located in the historic centre of Málaga. For accomodation we would like to recommend the AC Hotel Malaga Palacio. From the conference center it takes 3 minutes by foot to arrive at AC Hotel Malaga Palacio. RSVVW ‘17 does not have an arrangement with AC Hotel Malaga Palacio, bookings can be made through their website.
AC Malaga Palacio Hotel Cine Albéniz
Cortina Del Muelle, 1 Alcazabilla, 4
29015, Malaga, 29015, Málaga
rsvvw IS SPONSORED BY
The Organising Committee and the Board of ReSViNET would like to express gratitude and acknowledge the following companies and institutes for their generous support of the RSV Vaccines for the World conference 2017, organised by ReSViNET.
Nov 29 - Dec 1, 2017
ON-LINE REGISTRATION RSVVW
Here you will find information for participants and the scientific program
Here you will find information on support categories and benefits
Here you will find the information on abstract submission. Deadline: Friday, September 1, 2017.